Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
DEL PRIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionBarclays Plc
Latest Disclosed Ownership12,137 shares
Latest Disclosed Value $ 189,216
Barclays Plc ownership in TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 12,137 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $160,208 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 1,749 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 593.94% during the quarter. The current value of the position is $155,354 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (TKDA) in the form of stock options. The firm currently holds call options representing 5,200 of underlying shares valued at $81,068 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 12,137 10,388 593.94 189 656.00 0.0000
2026-03-31 2025-09-30 13F/A-3 TAKEDA PHARMACEUTICAL ADR 874060205 1,749 172 10.91 26 4.17 0.0000
2026-03-19 2025-09-30 13F/A-2 TAKEDA PHARMACEUTICAL ADR 874060205 1,339 -238 19 0.0000
2025-11-12 2025-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,749 172 26 0.0000
2026-02-27 2025-06-30 13F/A-2 TAKEDA PHARMACEUTICAL ADR 874060205 1,577 -77 -4.66 24 0.00 0.0000
2025-08-14 2025-06-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,577 -77 0 0.0000
2025-08-13 2025-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,577 -77 0 0.0000
2026-03-17 2025-03-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,654 709 75.03 25 100.00 0.0000
2025-05-15 2025-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,654 709 0 0.0000
2026-03-19 2024-12-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 945 -394 -29.42 13 -36.84 0.0000
2025-02-13 2024-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 945 -394 0 0.0000
2026-03-31 2024-09-30 13F/A-2 TAKEDA PHARMACEUTICAL ADR 874060205 1,339 1,337 66,850.00 19 0.0000
2024-11-19 2024-09-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,339 1,337 0 0.0000
2024-11-15 2024-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,339 1,337 0 0.0000
2026-03-23 2024-06-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 2 0 0.00 0 0.0000
2024-08-14 2024-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 2 0 0 0.0000
2026-03-24 2024-03-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 2 0 0.00 0 0.0000
2024-05-15 2024-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 2 0 0 0.0000
2026-03-25 2023-12-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 2 -1,578 -99.87 0 -100.00 0.0000
2024-02-15 2023-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 2 -1,578 0 0.0000
2026-03-26 2023-09-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,580 -50,256 -96.95 24 -97.05 0.0000
2023-11-07 2023-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,580 -50,256 0 0.0000
2026-03-30 2023-06-30 13F/A-2 TAKEDA PHARMACEUTICAL ADR 874060205 51,836 -1,638,505 -96.93 814 -97.08 0.0005
2023-09-20 2023-06-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 51,836 -1,638,505 1 0.0005
2023-08-03 2023-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 51,836 -1,638,505 1 0.0005
2026-03-30 2023-03-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,690,341 3,200 0.19 27,857 5.84 0.0128
2023-05-04 2023-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,690,341 3,200 28 0.0128
2026-03-30 2022-12-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,687,141 -2,900 -0.17 26,319 20.07 0.0118
2023-02-13 2022-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,687,141 -2,900 26 0.0118
2022-11-03 2022-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,690,041 3,069 0.18 21,919 -7.46 0.0239
2022-08-12 2022-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,686,972 0 0.00 23,685 -1.96 0.0145
2022-05-16 2022-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,686,972 246,199 17.09 24,158 23.02 0.0189
2022-02-23 2021-12-31 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 1,440,773 -41,087 -2.77 19,638 -19.10 0.0073
2022-02-14 2021-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,440,773 -41,087 19,638 0.0022
2021-11-09 2021-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,481,860 433,930 41.41 24,273 37.63 0.0109
2021-08-13 2021-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 1,047,930 465,182 79.83 17,637 65.76 0.0083
2021-05-13 2021-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 582,748 429,929 281.33 10,640 282.60 0.0057
2021-02-11 2020-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 152,819 -149,627 -49.47 2,781 -48.45 0.0015
2020-11-12 2020-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 302,446 -645 -0.21 5,395 -0.72 0.0032
2020-08-12 2020-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 303,091 -35,864 -10.58 5,434 5.62 0.0042
2020-05-13 2020-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 338,955 -71,157 -17.35 5,145 -36.41 0.0041
2020-02-10 2019-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 410,112 -24,100 -5.55 8,091 8.33 0.0045
2019-11-15 2019-09-30 13F/A-1 TAKEDA PHARMACEUTICAL ADR 874060205 434,212 128,577 42.07 7,469 38.03 0.0047
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 434,212 128,577 7,469 1,726.8412
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL ADR 874060205 305,635 52,076 20.54 5,411 4.76 0.0033
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 253,559 232,058 1,079.29 5,165 1,326.80 0.0036
2019-02-14 2018-12-31 13F TAKEDA PHARMACEUTICAL ADR 874060205 21,501 21,501 362 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F TAKEDA PHARMACEUTICAL OPT Call 5,200 81 n/a n/a n/a
2021-08-13 2021-06-30 13F TAKEDA PHARMACEUTICAL OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-13 2021-03-31 13F TAKEDA PHARMACEUTICAL OPT Call 150,000 -50.69 2,739 -50.53 n/a n/a n/a
2021-02-11 2020-12-31 13F TAKEDA PHARMACEUTICAL OPT Call 304,224 0.00 5,537 2.03 n/a n/a n/a
2020-11-12 2020-09-30 13F TAKEDA PHARMACEUTICAL OPT Call 304,224 -0.39 5,427 -0.91 n/a n/a n/a
2020-08-12 2020-06-30 13F TAKEDA PHARMACEUTICAL OPT Call 305,424 15.15 5,477 36.04 n/a n/a n/a
2020-05-13 2020-03-31 13F TAKEDA PHARMACEUTICAL OPT Call 265,236 -9.04 4,026 -30.03 n/a n/a n/a
2020-02-10 2019-12-31 13F TAKEDA PHARMACEUTICAL OPT Call 291,595 8.00 5,754 23.90 n/a n/a n/a
2019-11-15 2019-09-30 13F/A TAKEDA PHARMACEUTICAL OPT Call 269,995 -2.28 4,644 -5.03 n/a n/a n/a
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL OPT Call 269,995 4,644 n/a n/a n/a
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL OPT Call 276,299 57.32 4,890 36.67 n/a n/a n/a
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL OPT Call 175,626 3,578 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-08-13 2021-06-30 13F TAKEDA PHARMACEUTICAL OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-13 2021-03-31 13F TAKEDA PHARMACEUTICAL OPT Put 150,000 -29.52 2,739 -29.30 n/a n/a n/a
2021-02-11 2020-12-31 13F TAKEDA PHARMACEUTICAL OPT Put 212,830 0.00 3,874 2.03 n/a n/a n/a
2020-11-12 2020-09-30 13F TAKEDA PHARMACEUTICAL OPT Put 212,830 0.00 3,797 -0.52 n/a n/a n/a
2020-08-12 2020-06-30 13F TAKEDA PHARMACEUTICAL OPT Put 212,830 -24.85 3,817 -11.21 n/a n/a n/a
2020-05-13 2020-03-31 13F TAKEDA PHARMACEUTICAL OPT Put 283,218 -4.23 4,299 -26.32 n/a n/a n/a
2020-02-10 2019-12-31 13F TAKEDA PHARMACEUTICAL OPT Put 295,717 -0.10 5,835 14.61 n/a n/a n/a
2019-11-15 2019-09-30 13F/A TAKEDA PHARMACEUTICAL OPT Put 296,017 0.20 5,091 -2.64 n/a n/a n/a
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL OPT Put 296,017 5,091 n/a n/a n/a
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL OPT Put 295,421 9.41 5,229 -4.94 n/a n/a n/a
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL OPT Put 270,007 5,501 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.